Latest filing published 24 May 2024 for Phathom Pharmaceuticals, Inc..
Filing timeline
BuySaleInsider track record
David A. Socks: trading record in brief
This profile gathers the share dealings of David A. Socks across 2 companies, led by Phathom Pharmaceuticals, Inc. and Cadence Pharmaceuticals Inc. Over a trading history stretching from 20 February 2008 to 23 May 2024, the count stands at 77 filings.
The open-market record consists of 73 sales worth €15.9M, with no purchase. The rest of the record consists of 3 share grants and 1 option exercise.
The newest entry dates from 24 May 2024: a share grant, in Phathom Pharmaceuticals, Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to David A. Socks
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 10,500 shares0Common StockSEC:0000950170-24-064810:0
- 9,000 shares0Common StockSEC:0001209191-23-033020:0
- 2,529 shares@ US$32.050.5% of flowCommon StockSEC:0001209191-21-060109:1
- 15,471 shares@ US$32.663920.6% of flowCommon StockSEC:0001209191-21-060109:0
- 324 shares@ US$33.310.1% of flowCommon StockSEC:0001209191-21-057517:1
- 4,100 shares@ US$32.060.8% of flowCommon StockSEC:0001209191-21-057517:2
- 13,576 shares@ US$32.786817.9% of flowCommon StockSEC:0001209191-21-057517:0
- 13,791 shares@ US$31.492.5% of flowCommon StockSEC:0001209191-21-052287:1
- 4,209 shares@ US$30.47045.1% of flowCommon StockSEC:0001209191-21-052287:0
- 156 shares@ US$35.090.0% of flowCommon StockSEC:0001209191-21-043851:1
- 13,960 shares@ US$34.002.7% of flowCommon StockSEC:0001209191-21-043851:2
- 25,884 shares@ US$34.067834.9% of flowCommon StockSEC:0001209191-21-043851:0
- 16,020 shares@ US$32.782.9% of flowCommon StockSEC:0001209191-21-035068:1
- 3,229 shares@ US$33.380.6% of flowCommon StockSEC:0001209191-21-035068:2
- 899 shares@ US$33.760.2% of flowCommon StockSEC:0001209191-21-035068:3
- 2,278 shares@ US$34.930.4% of flowCommon StockSEC:0001209191-21-035068:4
- 305 shares@ US$35.270.1% of flowCommon StockSEC:0001209191-21-035068:5
- 17,269 shares@ US$31.955721.4% of flowCommon StockSEC:0001209191-21-035068:0
- 12,619 shares@ US$35.692.6% of flowCommon StockSEC:0001209191-21-025856:0
- 7,769 shares@ US$36.401.6% of flowCommon StockSEC:0001209191-21-025856:1
- 1,730 shares@ US$37.150.4% of flowCommon StockSEC:0001209191-21-025856:2
- 1,400 shares@ US$34.960.3% of flowCommon StockSEC:0001209191-21-025856:3
- 3,359 shares@ US$35.970.7% of flowCommon StockSEC:0001209191-21-025856:4
- 6,328 shares@ US$37.371.3% of flowCommon StockSEC:0001209191-21-025856:5
- 6,795 shares@ US$38.031.5% of flowCommon StockSEC:0001209191-21-025856:6
25 of 77 declarations
